Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. | 690,900 | reported | 07 Jan 2026 | tx 6+1,085,649 |
| Clovis Oncology, Inc. | 111,419 | reported | 02 Nov 2022 | tx 215+717,810−376,772 |
| Atreca, Inc. | 12,000 | reported | 13 Jun 2023 | tx 5+72,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Jan 2026 | GRANT_AWARD | CERO THERAPEUTICS HOLDINGS, INC. | 690,900 | 0.00 USD | deriv |
| 30 May 2025 | GRANT_AWARD | CERO THERAPEUTICS HOLDINGS, INC. | 9,326 | 0.00 USD | deriv |
| 04 Mar 2025 | GRANT_AWARD | CERO THERAPEUTICS HOLDINGS, INC. | 17,923 | 0.00 USD | deriv |
| 24 Feb 2025 | GRANT_AWARD | CERO THERAPEUTICS HOLDINGS, INC. | 127,500 | 0.00 USD | deriv |
| 02 Dec 2024 | GRANT_AWARD | CERO THERAPEUTICS HOLDINGS, INC. | 127,500 | 0.00 USD | deriv |
| 25 Mar 2024 | GRANT_AWARD | CERO THERAPEUTICS HOLDINGS, INC. | 112,500 | 0.00 USD | deriv |
| 13 Jun 2023 | GRANT_AWARD | Atreca, Inc. | 12,000 | 0.00 USD | deriv |
| 02 Nov 2022 | SALE | Clovis Oncology, Inc. | 2,353 | 0.98 USD | |
| 01 Nov 2022 | EXERCISE | Clovis Oncology, Inc. | 4,625 | — | |
| 02 Nov 2022 | SALE | Clovis Oncology, Inc. | 1,908 | 0.98 USD | |
| 01 Nov 2022 | EXERCISE | Clovis Oncology, Inc. | 3,749 | — | |
| 01 Nov 2022 | EXERCISE | Clovis Oncology, Inc. | 4,625 | 0.00 USD | deriv |
| 01 Nov 2022 | EXERCISE | Clovis Oncology, Inc. | 3,749 | 0.00 USD | deriv |
| 01 Sept 2022 | EXERCISE | Clovis Oncology, Inc. | 5,063 | — | |
| 02 Sept 2022 | SALE | Clovis Oncology, Inc. | 2,545 | 1.20 USD | |
| 01 Sept 2022 | EXERCISE | Clovis Oncology, Inc. | 5,063 | 0.00 USD | deriv |
| 02 Aug 2022 | SALE | Clovis Oncology, Inc. | 2,391 | 1.46 USD | |
| 01 Aug 2022 | EXERCISE | Clovis Oncology, Inc. | 4,625 | — | |
| 01 Aug 2022 | EXERCISE | Clovis Oncology, Inc. | 3,749 | — | |
| 02 Aug 2022 | SALE | Clovis Oncology, Inc. | 1,939 | 1.46 USD | |
| 01 Aug 2022 | EXERCISE | Clovis Oncology, Inc. | 3,749 | 0.00 USD | deriv |
| 01 Aug 2022 | EXERCISE | Clovis Oncology, Inc. | 4,625 | 0.00 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | Atreca, Inc. | 12,000 | 0.00 USD | deriv |
| 01 Jun 2022 | EXERCISE | Clovis Oncology, Inc. | 5,062 | — | |
| 02 Jun 2022 | SALE | Clovis Oncology, Inc. | 2,650 | 0.64 USD |